MiR-124 exhibits varied roles in different cancer types, with upregulation observed in Acute Lymphoblastic Leukemia (ALL), contributing to glucocorticoid resistance by suppressing the Glucocorticoid Receptor (NR3C1) [77]. Here, NR3C1 is linked to acute lymphoblastic leukemia.